speb/financial-data huggingface dataset:
CELL.V cash_flow (annual, 2024-06-30) — Common Stock Issuance: 480000.00
CELL.V income_statement (annual, 2024-06-30) — Cost Of Revenue: 10636.00
CELL.V balance_sheet (annual, 2024-06-30) — Current Accrued Expenses: 25000.00
CELL.V balance_sheet (annual, 2024-06-30) — Current Assets: 6190604.00
CELL.V balance_sheet (annual, 2024-06-30) — Current Capital Lease Obligation: 11194.00
CELL.V balance_sheet (annual, 2024-06-30) — Current Debt And Capital Lease Obligation: 11194.00
CELL.V balance_sheet (annual, 2024-06-30) — Current Liabilities: 137268.00
CELL.V cash_flow (annual, 2024-06-30) — Depreciation: 10636.00
CELL.V cash_flow (annual, 2024-06-30) — Depreciation Amortization Depletion: 10636.00
CELL.V cash_flow (annual, 2024-06-30) — Depreciation And Amortization: 10636.00
CELL.V income_statement (annual, 2024-06-30) — Diluted Average Shares: 185895159.00
CELL.V income_statement (annual, 2024-06-30) — Diluted EPS: -0.01
CELL.V income_statement (annual, 2024-06-30) — Diluted NI Availto Com Stockholders: -1365818.00
CELL.V income_statement (annual, 2024-06-30) — EBIT: -3450351.00
CELL.V income_statement (annual, 2024-06-30) — EBITDA: -3439715.00
CELL.V cash_flow (annual, 2024-06-30) — End Cash Position: 6067899.00
CELL.V cash_flow (annual, 2024-06-30) — Financing Cash Flow: 753000.00
CELL.V cash_flow (annual, 2024-06-30) — Free Cash Flow: -3329493.00
CELL.V cash_flow (annual, 2024-06-30) — Gain Loss On Investment Securities: -3451749.00
CELL.V cash_flow (annual, 2024-06-30) — Gain Loss On Sale Of PPE: 0.00
CELL.V income_statement (annual, 2024-06-30) — Gain On Sale Of Ppe: 0.00
CELL.V income_statement (annual, 2024-06-30) — Gain On Sale Of Security: 2036283.00
CELL.V balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: 5125879.00
CELL.V income_statement (annual, 2024-06-30) — General And Administrative Expense: 1452137.00
CELL.V balance_sheet (annual, 2024-06-30) — Gross PPE: 2130704.00
CELL.V income_statement (annual, 2024-06-30) — Gross Profit: -10636.00
CELL.V income_statement (annual, 2024-06-30) — Impairment Of Capital Assets: 0.00
CELL.V income_statement (annual, 2024-06-30) — Insurance And Claims: 30066.00
CELL.V income_statement (annual, 2024-06-30) — Interest Income: 51197.00
CELL.V income_statement (annual, 2024-06-30) — Interest Income Non Operating: 51197.00
CELL.V balance_sheet (annual, 2024-06-30) — Invested Capital: 8180105.00
CELL.V cash_flow (annual, 2024-06-30) — Investing Cash Flow: 4398245.00
CELL.V cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 480000.00
CELL.V balance_sheet (annual, 2024-06-30) — Long Term Capital Lease Obligation: 3935.00
CELL.V balance_sheet (annual, 2024-06-30) — Long Term Debt And Capital Lease Obligation: 3935.00
CELL.V cash_flow (annual, 2024-06-30) — Long Term Debt Payments: -12000.00
CELL.V cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 480000.00
CELL.V income_statement (annual, 2024-06-30) — Net Income: -1365818.00
CELL.V income_statement (annual, 2024-06-30) — Net Income Common Stockholders: -1365818.00
CELL.V income_statement (annual, 2024-06-30) — Net Income Continuous Operations: -1365818.00
CELL.V income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: -1365818.00
CELL.V income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: -1365818.00
CELL.V cash_flow (annual, 2024-06-30) — Net Income From Continuing Operations: -1365818.00
CELL.V income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: -1365818.00
CELL.V income_statement (annual, 2024-06-30) — Net Interest Income: 48250.00
CELL.V cash_flow (annual, 2024-06-30) — Net Investment Purchase And Sale: 5026749.00
CELL.V cash_flow (annual, 2024-06-30) — Net Issuance Payments Of Debt: -12000.00
CELL.V cash_flow (annual, 2024-06-30) — Net Long Term Debt Issuance: -12000.00
CELL.V income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: 48250.00
CELL.V cash_flow (annual, 2024-06-30) — Net Other Investing Changes: -628504.00
CELL.V balance_sheet (annual, 2024-06-30) — Net PPE: 2130704.00
CELL.V balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 8180105.00
CELL.V income_statement (annual, 2024-06-30) — Normalized EBITDA: -5475998.00
CELL.V income_statement (annual, 2024-06-30) — Normalized Income: -3402101.00
CELL.V cash_flow (annual, 2024-06-30) — Operating Cash Flow: -3329493.00
CELL.V cash_flow (annual, 2024-06-30) — Operating Gains Losses: -3451749.00
CELL.V income_statement (annual, 2024-06-30) — Operating Income: -3450351.00
CELL.V income_statement (annual, 2024-06-30) — Operating Revenue: 0.00
CELL.V balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 188280795.00
CELL.V income_statement (annual, 2024-06-30) — Other Gand A: 1422071.00
CELL.V income_statement (annual, 2024-06-30) — Other Income Expense: 2036283.00
CELL.V cash_flow (annual, 2024-06-30) — Other Non Cash Items: 1664.00
CELL.V income_statement (annual, 2024-06-30) — Other Operating Expenses: 1664.00
CELL.V balance_sheet (annual, 2024-06-30) — Other Properties: 2130704.00
CELL.V balance_sheet (annual, 2024-06-30) — Other Receivables: 28156.00
CELL.V balance_sheet (annual, 2024-06-30) — Other Short Term Investments: 0.00
CELL.V balance_sheet (annual, 2024-06-30) — Payables: 101074.00
CELL.V balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 126074.00
CELL.V balance_sheet (annual, 2024-06-30) — Prepaid Assets: 77460.00
CELL.V income_statement (annual, 2024-06-30) — Pretax Income: -1365818.00
CELL.V cash_flow (annual, 2024-06-30) — Proceeds From Stock Option Exercised: 285000.00
CELL.V balance_sheet (annual, 2024-06-30) — Receivables: 45245.00
CELL.V income_statement (annual, 2024-06-30) — Reconciled Cost Of Revenue: 10636.00
CELL.V income_statement (annual, 2024-06-30) — Reconciled Depreciation: 10636.00
CELL.V income_statement (annual, 2024-06-30) — Rent And Landing Fees: 0.00
CELL.V income_statement (annual, 2024-06-30) — Rent Expense Supplemental: 0.00
CELL.V cash_flow (annual, 2024-06-30) — Repayment Of Debt: -12000.00
CELL.V balance_sheet (annual, 2024-06-30) — Retained Earnings: -12205078.00
CELL.V income_statement (annual, 2024-06-30) — Salaries And Wages: 0.00
CELL.V cash_flow (annual, 2024-06-30) — Sale Of Investment: 5026749.00
CELL.V income_statement (annual, 2024-06-30) — Selling And Marketing Expense: 1985914.00
CELL.V income_statement (annual, 2024-06-30) — Selling General And Administration: 3438051.00
CELL.V balance_sheet (annual, 2024-06-30) — Share Issued: 188280795.00
CELL.V income_statement (annual, 2024-06-30) — Special Income Charges: 0.00
CELL.V cash_flow (annual, 2024-06-30) — Stock Based Compensation: 0.00
CELL.V balance_sheet (annual, 2024-06-30) — Stockholders Equity: 8180105.00
CELL.V balance_sheet (annual, 2024-06-30) — Tangible Book Value: 8180105.00
CELL.V income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
CELL.V income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.00
CELL.V balance_sheet (annual, 2024-06-30) — Taxes Receivable: 17089.00
CELL.V balance_sheet (annual, 2024-06-30) — Total Assets: 8321308.00
CELL.V balance_sheet (annual, 2024-06-30) — Total Capitalization: 8180105.00
CELL.V balance_sheet (annual, 2024-06-30) — Total Debt: 15129.00
CELL.V balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 8180105.00
CELL.V income_statement (annual, 2024-06-30) — Total Expenses: 3450351.00
CELL.V balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 141203.00
CELL.V balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 2130704.00
CELL.V balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 3935.00
CELL.V income_statement (annual, 2024-06-30) — Total Other Finance Cost: 2947.00
CELL.V income_statement (annual, 2024-06-30) — Total Unusual Items: 2036283.00
CELL.V income_statement (annual, 2024-06-30) — Total Unusual Items Excluding Goodwill: 2036283.00
CELL.V cash_flow (annual, 2024-06-30) — Unrealized Gain Loss On Investment Securities: 1425000.00
CELL.V balance_sheet (annual, 2024-06-30) — Working Capital: 6053336.00
CELL.V income_statement (quarterly, 2024-09-30) — Basic Average Shares: 188280795.00
CELL.V income_statement (quarterly, 2024-09-30) — Basic EPS: 0.00
CELL.V balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 11194.00
CELL.V income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 188280795.00
CELL.V income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.00
CELL.V balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 1220.00
CELL.V balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 1220.00
CELL.V cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: -309167.00
CELL.V balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 1.00
CELL.V balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: -1.00
CELL.V income_statement (quarterly, 2024-09-30) — Other Operating Expenses: 285.00
CELL.V balance_sheet (quarterly, 2024-09-30) — Payables: 177562.00
CELL.V income_statement (quarterly, 2024-12-31) — +Operating Expense: 1027271.00
CELL.V income_statement (quarterly, 2024-12-31) — +Total Revenue: 0.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 90460.00
CELL.V income_statement (quarterly, 2024-12-31) — Basic Average Shares: 188280795.00
CELL.V income_statement (quarterly, 2024-12-31) — Basic EPS: -0.01
CELL.V cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 5201493.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 9644.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Capital Stock: 15259304.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 3565182.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 3565182.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Cash Financial: 3565182.00
CELL.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: -3000.00
CELL.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -538476.00
CELL.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -1094836.00
CELL.V cash_flow (quarterly, 2024-12-31) — Change In Payable: -107104.00
CELL.V cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: -107104.00
CELL.V cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: 12661.00
CELL.V cash_flow (quarterly, 2024-12-31) — Change In Receivables: -4289.00
CELL.V cash_flow (quarterly, 2024-12-31) — Change In Working Capital: -98732.00
CELL.V cash_flow (quarterly, 2024-12-31) — Changes In Cash: -1636311.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Common Stock: 15259304.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 6460668.00
CELL.V cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
CELL.V income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 2659.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 0.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Current Assets: 3587742.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 9644.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 9644.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 100104.00
CELL.V cash_flow (quarterly, 2024-12-31) — Depreciation: 2659.00
CELL.V cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 2659.00
CELL.V cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 2659.00
CELL.V income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 188280795.00
CELL.V income_statement (quarterly, 2024-12-31) — Diluted EPS: -0.01
CELL.V income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -998991.00
CELL.V income_statement (quarterly, 2024-12-31) — EBIT: -1029930.00
CELL.V income_statement (quarterly, 2024-12-31) — EBITDA: -1027271.00
CELL.V cash_flow (quarterly, 2024-12-31) — End Cash Position: 3565182.00
CELL.V cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -3000.00
CELL.V cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -1094836.00
CELL.V income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: -8032.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 5125879.00
CELL.V income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 395406.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Gross PPE: 2973029.00
CELL.V income_statement (quarterly, 2024-12-31) — Gross Profit: -2659.00
CELL.V income_statement (quarterly, 2024-12-31) — Insurance And Claims: 15463.00
CELL.V income_statement (quarterly, 2024-12-31) — Interest Income: 39689.00
CELL.V income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 39689.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Invested Capital: 6460668.00
CELL.V cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -538476.00
CELL.V cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
CELL.V cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -3000.00
CELL.V cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
CELL.V income_statement (quarterly, 2024-12-31) — Net Income: -998991.00
CELL.V income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -998991.00
CELL.V income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -998992.00
CELL.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -998991.00
CELL.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -998991.00
CELL.V cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -998993.00
CELL.V income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -998992.00
CELL.V income_statement (quarterly, 2024-12-31) — Net Interest Income: 38970.00
CELL.V cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
CELL.V cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -3000.00
CELL.V cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -3000.00
CELL.V income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: 38970.00
CELL.V cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: -538476.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Net PPE: 2973029.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 6460668.00
CELL.V income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -1019239.00
CELL.V income_statement (quarterly, 2024-12-31) — Normalized Income: -990959.00
CELL.V cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -1094836.00
CELL.V income_statement (quarterly, 2024-12-31) — Operating Income: -1029930.00
CELL.V income_statement (quarterly, 2024-12-31) — Operating Revenue: 0.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 188280795.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Other Current Assets: -1.00
CELL.V income_statement (quarterly, 2024-12-31) — Other Gand A: 379943.00
CELL.V income_statement (quarterly, 2024-12-31) — Other Income Expense: -8032.00
CELL.V cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 230.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: -1.00
CELL.V income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 230.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Other Properties: 2973029.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Payables: 90460.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 90460.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 8702.00
CELL.V income_statement (quarterly, 2024-12-31) — Pretax Income: -998992.00
CELL.V cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Receivables: 13859.00
CELL.V income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 2659.00
CELL.V income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 2659.00
CELL.V income_statement (quarterly, 2024-12-31) — Rent And Landing Fees: 0.00
CELL.V income_statement (quarterly, 2024-12-31) — Rent Expense Supplemental: 0.00
CELL.V cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -3000.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -13924515.00
CELL.V cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 0.00
CELL.V income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 631635.00
CELL.V income_statement (quarterly, 2024-12-31) — Selling General And Administration: 1027041.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Share Issued: 188280795.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 6460668.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 6460668.00
CELL.V income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CELL.V income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 13859.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Total Assets: 6560771.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 6460668.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Total Debt: 9644.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 6460668.00
CELL.V income_statement (quarterly, 2024-12-31) — Total Expenses: 1029930.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 100103.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 2973029.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: -1.00
CELL.V income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: 719.00
CELL.V income_statement (quarterly, 2024-12-31) — Total Unusual Items: -8032.00
CELL.V income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -8032.00
CELL.V cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
CELL.V balance_sheet (quarterly, 2024-12-31) — Working Capital: 3487638.00
CELL.V income_statement (quarterly, 2025-03-31) — +Operating Expense: 1506770.00
CELL.V income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 0.00
CELL.V income_statement (quarterly, 2025-03-31) — Basic Average Shares: 189058573.00
CELL.V income_statement (quarterly, 2025-03-31) — Basic EPS: -0.01
CELL.V cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 3565182.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 6818.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Capital Stock: 15509304.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1866767.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1866767.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1866767.00
CELL.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -3000.00
CELL.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -69855.00
CELL.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1625558.00
CELL.V cash_flow (quarterly, 2025-03-31) — Change In Payable: -90459.00
CELL.V cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -90459.00
CELL.V cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 4059.00
CELL.V cash_flow (quarterly, 2025-03-31) — Change In Receivables: 3047.00
CELL.V cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -83353.00
CELL.V cash_flow (quarterly, 2025-03-31) — Changes In Cash: -1698415.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Common Stock: 15509304.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 5165630.00
CELL.V cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
CELL.V income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2659.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 0.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Current Assets: 1882221.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 6818.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 6818.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 6818.00
CELL.V cash_flow (quarterly, 2025-03-31) — Depreciation: 2659.00
CELL.V cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 2659.00
CELL.V cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 2659.00
CELL.V income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 189058573.00
CELL.V income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.01
CELL.V income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -1545037.00
CELL.V income_statement (quarterly, 2025-03-31) — EBIT: -1509429.00
CELL.V income_statement (quarterly, 2025-03-31) — EBITDA: -1506770.00
CELL.V cash_flow (quarterly, 2025-03-31) — End Cash Position: 1866767.00
CELL.V cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -3000.00
CELL.V cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -2543057.00
CELL.V income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -56375.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 5125879.00
CELL.V income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 435572.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Gross PPE: 3290226.00
CELL.V income_statement (quarterly, 2025-03-31) — Gross Profit: -2659.00
CELL.V income_statement (quarterly, 2025-03-31) — Insurance And Claims: 12949.00
CELL.V income_statement (quarterly, 2025-03-31) — Interest Income: 21434.00
CELL.V income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 21434.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Invested Capital: 5165630.00
CELL.V cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -69855.00
CELL.V cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 0.00
CELL.V cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -3000.00
CELL.V cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CELL.V income_statement (quarterly, 2025-03-31) — Net Income: -1545037.00
CELL.V income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -1545037.00
CELL.V income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -1545037.00
CELL.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1545037.00
CELL.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1545037.00
CELL.V cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -1545038.00
CELL.V income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -1545037.00
CELL.V income_statement (quarterly, 2025-03-31) — Net Interest Income: 20767.00
CELL.V cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
CELL.V cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -3000.00
CELL.V cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -3000.00
CELL.V income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 20767.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Net PPE: 3290226.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 5165630.00
CELL.V income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -1450395.00
CELL.V income_statement (quarterly, 2025-03-31) — Normalized Income: -1488662.00
CELL.V cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1625559.00
CELL.V income_statement (quarterly, 2025-03-31) — Operating Income: -1509429.00
CELL.V income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 193280795.00
CELL.V income_statement (quarterly, 2025-03-31) — Other Gand A: 422623.00
CELL.V income_statement (quarterly, 2025-03-31) — Other Income Expense: -56375.00
CELL.V cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 173.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: -1.00
CELL.V income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 174.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Other Properties: 3290226.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 0.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 4642.00
CELL.V income_statement (quarterly, 2025-03-31) — Pretax Income: -1545037.00
CELL.V cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Receivables: 10812.00
CELL.V income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2659.00
CELL.V income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2659.00
CELL.V cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -3000.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -15469553.00
CELL.V cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
CELL.V income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 1071024.00
CELL.V income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1506596.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Share Issued: 193280795.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 5165630.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 5165630.00
CELL.V income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CELL.V income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 10812.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Total Assets: 5172447.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 5165630.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Total Debt: 6818.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 5165630.00
CELL.V income_statement (quarterly, 2025-03-31) — Total Expenses: 1509429.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 6817.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3290226.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: -1.00
CELL.V income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 667.00
CELL.V income_statement (quarterly, 2025-03-31) — Total Unusual Items: -56375.00
CELL.V income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -56375.00
CELL.V cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 0.00
CELL.V balance_sheet (quarterly, 2025-03-31) — Working Capital: 1875403.00
CELL.V income_statement (annual, 2025-06-30) — +Operating Expense: 3844376.00
CELL.V income_statement (quarterly, 2025-06-30) — +Operating Expense: 541288.00
CELL.V income_statement (annual, 2025-06-30) — +Total Revenue: 0.00
CELL.V income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
CELL.V balance_sheet (annual, 2025-06-30) — Accounts Payable: 44070.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 44070.00
CELL.V cash_flow (annual, 2025-06-30) — Asset Impairment Charge: 74886.00
CELL.V income_statement (annual, 2025-06-30) — Basic Average Shares: 189726274.00
CELL.V income_statement (annual, 2025-06-30) — Basic EPS: -0.02
CELL.V cash_flow (annual, 2025-06-30) — Beginning Cash Position: 6067899.00
CELL.V cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1866767.00
CELL.V balance_sheet (annual, 2025-06-30) — Capital Lease Obligations: 3935.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 3935.00
CELL.V balance_sheet (annual, 2025-06-30) — Capital Stock: 15389804.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Capital Stock: 15389804.00
CELL.V balance_sheet (annual, 2025-06-30) — Cash And Cash Equivalents: 1173480.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1173480.00
CELL.V balance_sheet (annual, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1173480.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1173480.00
CELL.V balance_sheet (annual, 2025-06-30) — Cash Financial: 1173480.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Cash Financial: 1173480.00
CELL.V cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Financing Activities: -6500.00
CELL.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 2500.00
CELL.V cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Investing Activities: -909847.00
CELL.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 7651.00
CELL.V cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Operating Activities: -3978072.00
CELL.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -703439.00
CELL.V cash_flow (annual, 2025-06-30) — Change In Payable: -57004.00
CELL.V cash_flow (quarterly, 2025-06-30) — Change In Payable: 69071.00
CELL.V cash_flow (annual, 2025-06-30) — Change In Payables And Accrued Expense: -57004.00
CELL.V cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 69071.00
CELL.V cash_flow (annual, 2025-06-30) — Change In Prepaid Assets: -154924.00
CELL.V cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -227742.00
CELL.V cash_flow (annual, 2025-06-30) — Change In Receivables: 36089.00
CELL.V cash_flow (quarterly, 2025-06-30) — Change In Receivables: 1656.00
CELL.V cash_flow (annual, 2025-06-30) — Change In Working Capital: -175839.00
CELL.V cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -157015.00
CELL.V cash_flow (annual, 2025-06-30) — Changes In Cash: -4894419.00
CELL.V cash_flow (quarterly, 2025-06-30) — Changes In Cash: -693287.00
CELL.V balance_sheet (annual, 2025-06-30) — Common Stock: 15389804.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Common Stock: 15389804.00
CELL.V balance_sheet (annual, 2025-06-30) — Common Stock Equity: 4422044.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 4422044.00
CELL.V cash_flow (annual, 2025-06-30) — Common Stock Issuance: 0.00
CELL.V cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
CELL.V income_statement (annual, 2025-06-30) — Cost Of Revenue: 10636.00
CELL.V income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2659.00
CELL.V balance_sheet (annual, 2025-06-30) — Current Accrued Expenses: 25000.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 25000.00
CELL.V balance_sheet (annual, 2025-06-30) — Current Assets: 1415020.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Current Assets: 1415020.00
CELL.V balance_sheet (annual, 2025-06-30) — Current Capital Lease Obligation: 3935.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 3935.00
CELL.V balance_sheet (annual, 2025-06-30) — Current Debt And Capital Lease Obligation: 3935.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 3935.00
CELL.V balance_sheet (annual, 2025-06-30) — Current Liabilities: 73005.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 73005.00
CELL.V cash_flow (annual, 2025-06-30) — Depreciation: 10636.00
CELL.V cash_flow (quarterly, 2025-06-30) — Depreciation: 2659.00
CELL.V cash_flow (annual, 2025-06-30) — Depreciation Amortization Depletion: 10636.00
CELL.V cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2659.00
CELL.V cash_flow (annual, 2025-06-30) — Depreciation And Amortization: 10636.00
CELL.V cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2659.00
CELL.V income_statement (annual, 2025-06-30) — Diluted Average Shares: 189726274.00
CELL.V income_statement (annual, 2025-06-30) — Diluted EPS: -0.02
CELL.V income_statement (annual, 2025-06-30) — Diluted NI Availto Com Stockholders: -3888561.00
CELL.V income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -624086.00
CELL.V income_statement (annual, 2025-06-30) — EBIT: -3855012.00
CELL.V income_statement (quarterly, 2025-06-30) — EBIT: -543947.00
CELL.V income_statement (annual, 2025-06-30) — EBITDA: -3844376.00
CELL.V income_statement (quarterly, 2025-06-30) — EBITDA: -541288.00
CELL.V cash_flow (annual, 2025-06-30) — End Cash Position: 1173480.00
CELL.V cash_flow (quarterly, 2025-06-30) — End Cash Position: 1173480.00
CELL.V cash_flow (annual, 2025-06-30) — Financing Cash Flow: -6500.00
CELL.V cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 2500.00
CELL.V cash_flow (annual, 2025-06-30) — Free Cash Flow: -3978072.00
CELL.V cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 214060.00
CELL.V income_statement (annual, 2025-06-30) — Gain On Sale Of Security: -60693.00
CELL.V income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 1295.00
CELL.V balance_sheet (annual, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 5125879.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 5125879.00
CELL.V income_statement (annual, 2025-06-30) — General And Administrative Expense: 1560662.00
CELL.V income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 441197.00
CELL.V balance_sheet (annual, 2025-06-30) — Gross PPE: 3080029.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Gross PPE: 3080029.00
CELL.V income_statement (annual, 2025-06-30) — Gross Profit: -10636.00
CELL.V income_statement (quarterly, 2025-06-30) — Gross Profit: -2659.00
CELL.V income_statement (annual, 2025-06-30) — Impairment Of Capital Assets: 74886.00
CELL.V income_statement (annual, 2025-06-30) — Insurance And Claims: 47850.00
CELL.V income_statement (quarterly, 2025-06-30) — Insurance And Claims: 8948.00
CELL.V income_statement (annual, 2025-06-30) — Interest Income: 104653.00
CELL.V income_statement (quarterly, 2025-06-30) — Interest Income: -6042.00
CELL.V income_statement (annual, 2025-06-30) — Interest Income Non Operating: 104653.00
CELL.V income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: -6042.00
CELL.V balance_sheet (annual, 2025-06-30) — Invested Capital: 4422044.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Invested Capital: 4422044.00
CELL.V cash_flow (annual, 2025-06-30) — Investing Cash Flow: -909847.00
CELL.V cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 7651.00
CELL.V cash_flow (annual, 2025-06-30) — Issuance Of Capital Stock: 0.00
CELL.V cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
CELL.V balance_sheet (annual, 2025-06-30) — Long Term Capital Lease Obligation: 0.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 0.00
CELL.V cash_flow (annual, 2025-06-30) — Long Term Debt Payments: -12000.00
CELL.V cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -3000.00
CELL.V cash_flow (annual, 2025-06-30) — Net Common Stock Issuance: 0.00
CELL.V cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
CELL.V income_statement (annual, 2025-06-30) — Net Income: -3888561.00
CELL.V income_statement (quarterly, 2025-06-30) — Net Income: -624086.00
CELL.V income_statement (annual, 2025-06-30) — Net Income Common Stockholders: -3888561.00
CELL.V income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -624086.00
CELL.V income_statement (annual, 2025-06-30) — Net Income Continuous Operations: -3888561.00
CELL.V income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -624086.00
CELL.V income_statement (annual, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -3888561.00
CELL.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -624086.00
CELL.V income_statement (annual, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -3888561.00
CELL.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -624086.00
CELL.V cash_flow (annual, 2025-06-30) — Net Income From Continuing Operations: -3888561.00
CELL.V cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -624086.00
CELL.V income_statement (annual, 2025-06-30) — Net Income Including Noncontrolling Interests: -3888561.00
CELL.V income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -624086.00
CELL.V income_statement (annual, 2025-06-30) — Net Interest Income: 102030.00
CELL.V income_statement (quarterly, 2025-06-30) — Net Interest Income: -6548.00
CELL.V cash_flow (annual, 2025-06-30) — Net Investment Purchase And Sale: 0.00
CELL.V cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
CELL.V cash_flow (annual, 2025-06-30) — Net Issuance Payments Of Debt: -12000.00
CELL.V cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -3000.00
CELL.V cash_flow (annual, 2025-06-30) — Net Long Term Debt Issuance: -12000.00
CELL.V cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -3000.00
CELL.V income_statement (annual, 2025-06-30) — Net Non Operating Interest Income Expense: 102030.00
CELL.V income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -6548.00
CELL.V cash_flow (annual, 2025-06-30) — Net Other Investing Changes: -909847.00
CELL.V balance_sheet (annual, 2025-06-30) — Net PPE: 3080029.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Net PPE: 3080029.00
CELL.V balance_sheet (annual, 2025-06-30) — Net Tangible Assets: 4422044.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 4422044.00
CELL.V income_statement (annual, 2025-06-30) — Normalized EBITDA: -3708797.00
CELL.V income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -467697.00
CELL.V income_statement (annual, 2025-06-30) — Normalized Income: -3752982.00
CELL.V income_statement (quarterly, 2025-06-30) — Normalized Income: -550495.00
CELL.V cash_flow (annual, 2025-06-30) — Operating Cash Flow: -3978072.00
CELL.V cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -703438.00
CELL.V income_statement (annual, 2025-06-30) — Operating Income: -3855012.00
CELL.V income_statement (quarterly, 2025-06-30) — Operating Income: -543947.00
CELL.V income_statement (annual, 2025-06-30) — Operating Revenue: 0.00
CELL.V income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
CELL.V balance_sheet (annual, 2025-06-30) — Ordinary Shares Number: 193380795.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 193380795.00
CELL.V income_statement (annual, 2025-06-30) — Other Gand A: 1512812.00
CELL.V income_statement (quarterly, 2025-06-30) — Other Gand A: 432249.00
CELL.V income_statement (annual, 2025-06-30) — Other Income Expense: -135579.00
CELL.V income_statement (quarterly, 2025-06-30) — Other Income Expense: -73591.00
CELL.V cash_flow (annual, 2025-06-30) — Other Non Cash Items: 806.00
CELL.V cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 118.00
CELL.V income_statement (annual, 2025-06-30) — Other Operating Expenses: 806.00
CELL.V income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 117.00
CELL.V balance_sheet (annual, 2025-06-30) — Other Properties: 3080029.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Other Properties: 3080029.00
CELL.V balance_sheet (annual, 2025-06-30) — Payables: 44070.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Payables: 44070.00
CELL.V balance_sheet (annual, 2025-06-30) — Payables And Accrued Expenses: 69070.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 69070.00
CELL.V balance_sheet (annual, 2025-06-30) — Prepaid Assets: 232384.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 232384.00
CELL.V income_statement (annual, 2025-06-30) — Pretax Income: -3888561.00
CELL.V income_statement (quarterly, 2025-06-30) — Pretax Income: -624086.00
CELL.V cash_flow (annual, 2025-06-30) — Proceeds From Stock Option Exercised: 5500.00
CELL.V cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 5500.00
CELL.V balance_sheet (annual, 2025-06-30) — Receivables: 9156.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Receivables: 9156.00
CELL.V income_statement (annual, 2025-06-30) — Reconciled Cost Of Revenue: 10636.00
CELL.V income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2659.00
CELL.V income_statement (annual, 2025-06-30) — Reconciled Depreciation: 10636.00
CELL.V income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2659.00
CELL.V cash_flow (annual, 2025-06-30) — Repayment Of Debt: -12000.00
CELL.V cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -3000.00
CELL.V balance_sheet (annual, 2025-06-30) — Retained Earnings: -16093639.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -16093639.00
CELL.V cash_flow (annual, 2025-06-30) — Sale Of Investment: 0.00
CELL.V cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
CELL.V income_statement (annual, 2025-06-30) — Selling And Marketing Expense: 2282908.00
CELL.V income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 99974.00
CELL.V income_statement (annual, 2025-06-30) — Selling General And Administration: 3843570.00
CELL.V income_statement (quarterly, 2025-06-30) — Selling General And Administration: 541171.00
CELL.V balance_sheet (annual, 2025-06-30) — Share Issued: 193380795.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Share Issued: 193380795.00
CELL.V income_statement (annual, 2025-06-30) — Special Income Charges: -74886.00
CELL.V balance_sheet (annual, 2025-06-30) — Stockholders Equity: 4422044.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 4422044.00
CELL.V balance_sheet (annual, 2025-06-30) — Tangible Book Value: 4422044.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 4422044.00
CELL.V income_statement (annual, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CELL.V income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CELL.V income_statement (annual, 2025-06-30) — Tax Rate For Calcs: 0.00
CELL.V income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CELL.V balance_sheet (annual, 2025-06-30) — Taxes Receivable: 9156.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 9156.00
CELL.V balance_sheet (annual, 2025-06-30) — Total Assets: 4495049.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Total Assets: 4495049.00
CELL.V balance_sheet (annual, 2025-06-30) — Total Capitalization: 4422044.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 4422044.00
CELL.V balance_sheet (annual, 2025-06-30) — Total Debt: 3935.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Total Debt: 3935.00
CELL.V balance_sheet (annual, 2025-06-30) — Total Equity Gross Minority Interest: 4422044.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 4422044.00
CELL.V income_statement (annual, 2025-06-30) — Total Expenses: 3855012.00
CELL.V income_statement (quarterly, 2025-06-30) — Total Expenses: 543947.00
CELL.V balance_sheet (annual, 2025-06-30) — Total Liabilities Net Minority Interest: 73005.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 73005.00
CELL.V balance_sheet (annual, 2025-06-30) — Total Non Current Assets: 3080029.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 3080029.00
CELL.V balance_sheet (annual, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CELL.V income_statement (annual, 2025-06-30) — Total Other Finance Cost: 2623.00
CELL.V income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 506.00
CELL.V income_statement (annual, 2025-06-30) — Total Unusual Items: -135579.00
CELL.V income_statement (quarterly, 2025-06-30) — Total Unusual Items: -73591.00
CELL.V income_statement (annual, 2025-06-30) — Total Unusual Items Excluding Goodwill: -135579.00
CELL.V income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -73591.00
CELL.V cash_flow (annual, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 0.00
CELL.V cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 0.00
CELL.V balance_sheet (annual, 2025-06-30) — Working Capital: 1342015.00
CELL.V balance_sheet (quarterly, 2025-06-30) — Working Capital: 1342015.00
CELL.V income_statement (quarterly, 2025-09-30) — +Operating Expense: 315846.00
CELL.V income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 20604.00
CELL.V income_statement (quarterly, 2025-09-30) — Basic Average Shares: 190380795.00
CELL.V income_statement (quarterly, 2025-09-30) — Basic EPS: 0.00
CELL.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1173480.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 994.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 15389804.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 862650.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 862650.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Cash Financial: 862650.00
CELL.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -3000.00
CELL.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -58181.00
CELL.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -249650.00
CELL.V cash_flow (quarterly, 2025-09-30) — Change In Payable: -28466.00
CELL.V cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -28466.00
CELL.V cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 90063.00
CELL.V cash_flow (quarterly, 2025-09-30) — Change In Receivables: 435.00
CELL.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 62032.00
CELL.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: -310831.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 15389804.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 4107645.00
CELL.V cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CELL.V income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2659.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 20000.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 1013692.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 994.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 994.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 41598.00
CELL.V cash_flow (quarterly, 2025-09-30) — Depreciation: 2659.00
CELL.V cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 2659.00
CELL.V cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 2659.00
CELL.V income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 190380795.00
CELL.V income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.00
CELL.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -314400.00
CELL.V income_statement (quarterly, 2025-09-30) — EBIT: -318505.00
CELL.V income_statement (quarterly, 2025-09-30) — EBITDA: -315846.00
CELL.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 862649.00
CELL.V cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -3000.00
CELL.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -249650.00
CELL.V income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 1892.00